134 related articles for article (PubMed ID: 29475078)
21. Volumes of lateral temporal and parietal structures distinguish between healthy aging, mild cognitive impairment, and Alzheimer's disease.
Hänggi J; Streffer J; Jäncke L; Hock C
J Alzheimers Dis; 2011; 26(4):719-34. PubMed ID: 21709375
[TBL] [Abstract][Full Text] [Related]
22. Cognitive MMN and P300 in mild cognitive impairment and Alzheimer's disease: A high density EEG-3D vector field tomography approach.
Papadaniil CD; Kosmidou VE; Tsolaki A; Tsolaki M; Kompatsiaris IY; Hadjileontiadis LJ
Brain Res; 2016 Oct; 1648(Pt A):425-433. PubMed ID: 27485659
[TBL] [Abstract][Full Text] [Related]
23. Vocal emotion processing deficits in HIV-infected individuals.
González-Baeza A; Arribas JR; Pérez-Valero I; Monge S; Bayón C; Martín P; Rubio S; Carvajal F
J Neurovirol; 2017 Apr; 23(2):304-312. PubMed ID: 27943048
[TBL] [Abstract][Full Text] [Related]
24. Lateral temporal hyper-activation as a novel biomarker of mild cognitive impairment.
Faraco CC; Puente AN; Brown C; Terry DP; Stephen Miller L
Neuropsychologia; 2013 Sep; 51(11):2281-93. PubMed ID: 23933482
[TBL] [Abstract][Full Text] [Related]
25. Family history of Alzheimer's disease and hippocampal structure in healthy people.
Donix M; Burggren AC; Suthana NA; Siddarth P; Ekstrom AD; Krupa AK; Jones M; Martin-Harris L; Ercoli LM; Miller KJ; Small GW; Bookheimer SY
Am J Psychiatry; 2010 Nov; 167(11):1399-406. PubMed ID: 20686185
[TBL] [Abstract][Full Text] [Related]
26. Effect of mild cognitive impairment and APOE genotype on resting cerebral blood flow and its association with cognition.
Wierenga CE; Dev SI; Shin DD; Clark LR; Bangen KJ; Jak AJ; Rissman RA; Liu TT; Salmon DP; Bondi MW
J Cereb Blood Flow Metab; 2012 Aug; 32(8):1589-99. PubMed ID: 22549621
[TBL] [Abstract][Full Text] [Related]
27. Baseline and longitudinal patterns of hippocampal connectivity in mild cognitive impairment: evidence from resting state fMRI.
Wang Z; Liang P; Jia X; Qi Z; Yu L; Yang Y; Zhou W; Lu J; Li K
J Neurol Sci; 2011 Oct; 309(1-2):79-85. PubMed ID: 21821265
[TBL] [Abstract][Full Text] [Related]
28. White matter hyperintensities are positively associated with cortical thickness in Alzheimer's disease.
Jacobs HI; Clerx L; Gronenschild EH; Aalten P; Verhey FR
J Alzheimers Dis; 2014; 39(2):409-22. PubMed ID: 24169238
[TBL] [Abstract][Full Text] [Related]
29. Multimodal imaging in mild cognitive impairment: Metabolism, morphometry and diffusion of the temporal-parietal memory network.
Walhovd KB; Fjell AM; Amlien I; Grambaite R; Stenset V; Bjørnerud A; Reinvang I; Gjerstad L; Cappelen T; Due-Tønnessen P; Fladby T
Neuroimage; 2009 Mar; 45(1):215-23. PubMed ID: 19056499
[TBL] [Abstract][Full Text] [Related]
30. Mild cognitive impairment in patients with Parkinson's disease is associated with increased cortical degeneration.
Hanganu A; Bedetti C; Jubault T; Gagnon JF; Mejia-Constain B; Degroot C; Lafontaine AL; Chouinard S; Monchi O
Mov Disord; 2013 Sep; 28(10):1360-9. PubMed ID: 23801590
[TBL] [Abstract][Full Text] [Related]
31. The influence of age and mild cognitive impairment on associative memory performance and underlying brain networks.
Oedekoven CS; Jansen A; Keidel JL; Kircher T; Leube D
Brain Imaging Behav; 2015 Dec; 9(4):776-89. PubMed ID: 25381653
[TBL] [Abstract][Full Text] [Related]
32. Large intracranial volume accelerates conversion to dementia in males and APOE4 non-carriers with mild cognitive impairment.
An H; Son SJ; Cho S; Cho EY; Choi B; Kim SY;
Int Psychogeriatr; 2016 May; 28(5):769-78. PubMed ID: 26674540
[TBL] [Abstract][Full Text] [Related]
33. Apolipoprotein E genotype is not associated with cognitive impairment in older adults with bipolar disorder.
Kerr DS; Stella F; Radanovic M; Aprahamian I; Bertollucci PH; Forlenza OV
Bipolar Disord; 2016 Feb; 18(1):71-7. PubMed ID: 26877211
[TBL] [Abstract][Full Text] [Related]
34. Association between Cerebrospinal Fluid Biomarkers for Alzheimer's Disease, APOE Genotypes and Auditory Verbal Learning Task in Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease.
Mandecka M; Budziszewska M; Barczak A; Pepłońska B; Chodakowska-Żebrowska M; Filipek-Gliszczyńska A; Nesteruk M; Styczyńska M; Barcikowska M; Gabryelewicz T
J Alzheimers Dis; 2016 Jul; 54(1):157-68. PubMed ID: 27472875
[TBL] [Abstract][Full Text] [Related]
35. Joint effects of gray matter atrophy and altered functional connectivity on cognitive deficits in amnestic mild cognitive impairment patients.
Xie C; Bai F; Yuan B; Yu H; Shi Y; Yuan Y; Wu D; Zhang ZS; Zhang ZJ
Psychol Med; 2015 Jul; 45(9):1799-810. PubMed ID: 25511078
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic differentiation of mild cognitive impairment due to Alzheimer's disease using a hippocampus-dependent test of spatial memory.
Moodley K; Minati L; Contarino V; Prioni S; Wood R; Cooper R; D'Incerti L; Tagliavini F; Chan D
Hippocampus; 2015 Aug; 25(8):939-51. PubMed ID: 25605659
[TBL] [Abstract][Full Text] [Related]
37. Preservation of episodic memory in semantic dementia: The importance of regions beyond the medial temporal lobes.
Irish M; Bunk S; Tu S; Kamminga J; Hodges JR; Hornberger M; Piguet O
Neuropsychologia; 2016 Jan; 81():50-60. PubMed ID: 26683384
[TBL] [Abstract][Full Text] [Related]
38. Apolipoprotein E ε4 and age effects on florbetapir positron emission tomography in healthy aging and Alzheimer disease.
Fleisher AS; Chen K; Liu X; Ayutyanont N; Roontiva A; Thiyyagura P; Protas H; Joshi AD; Sabbagh M; Sadowsky CH; Sperling RA; Clark CM; Mintun MA; Pontecorvo MJ; Coleman RE; Doraiswamy PM; Johnson KA; Carpenter AP; Skovronsky DM; Reiman EM
Neurobiol Aging; 2013 Jan; 34(1):1-12. PubMed ID: 22633529
[TBL] [Abstract][Full Text] [Related]
39. Multicentre variability of MRI-based medial temporal lobe volumetry in Alzheimer's disease.
Teipel SJ; Ewers M; Wolf S; Jessen F; Kölsch H; Arlt S; Luckhaus C; Schönknecht P; Schmidtke K; Heuser I; Frölich L; Ende G; Pantel J; Wiltfang J; Rakebrandt F; Peters O; Born C; Kornhuber J; Hampel H
Psychiatry Res; 2010 Jun; 182(3):244-50. PubMed ID: 20493672
[TBL] [Abstract][Full Text] [Related]
40. Topographical APOE ɛ4 Genotype Influence on Cerebral Metabolism in the Continuum of Alzheimer's Disease: Amyloid Burden Adjusted Analysis.
Seo EH; Kim SH; Park SH; Kang SH; Choo IH;
J Alzheimers Dis; 2016 Sep; 54(2):559-68. PubMed ID: 27567846
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
